{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:17:58Z","timestamp":1792804678962,"version":"4.5.0"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,18]],"date-time":"2019-08-18T00:00:00Z","timestamp":1566086400000},"content-version":"am","delay-in-days":290,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006370","name":"SBIR","doi-asserted-by":"publisher","award":["UH2TR000516"],"award-info":[{"award-number":["UH2TR000516"]}],"id":[{"id":"10.13039\/100006370","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.biomaterials.2018.07.062","type":"journal-article","created":{"date-parts":[[2018,8,4]],"date-time":"2018-08-04T05:28:19Z","timestamp":1533360499000},"page":"176-190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":175,"special_numbering":"C","title":["Investigation of the effect of hepatic metabolism on off-target cardiotoxicity in a multi-organ human-on-a-chip system"],"prefix":"10.1016","volume":"182","author":[{"given":"Carlota","family":"Oleaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Riu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Rothemund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Lavado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher W.","family":"McAleer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisha","family":"Persaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narasimhan Sriram","family":"Narasimhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"My","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffry","family":"Roles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Carmona-Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Sasserath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel H.","family":"Elbrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Kumanchik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Richard","family":"Bridges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candace","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark T.","family":"Schnepper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail","family":"Ekman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying I.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reine","family":"Note","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Langer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Teissier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Hickman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"D1","key":"10.1016\/j.biomaterials.2018.07.062_bib1","doi-asserted-by":"crossref","first-page":"D1080","DOI":"10.1093\/nar\/gkv1192","article-title":"WITHDRAWN--a resource for withdrawn and discontinued drugs","volume":"44","author":"Siramshetty","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.biomaterials.2018.07.062_bib2","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1089\/aivt.2016.0002","article-title":"Cardiovascular organ-on-a-chip platforms for drug discovery and development","volume":"2","author":"Ribas","year":"2016","journal-title":"Applied In Vitro Toxicology"},{"issue":"6","key":"10.1016\/j.biomaterials.2018.07.062_bib3","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nrd4309","article-title":"Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework","volume":"13","author":"Cook","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biomaterials.2018.07.062_bib4","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.addr.2013.12.003","article-title":"How multi-organ microdevices can help foster drug development","volume":"69\u201370","author":"Esch","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.biomaterials.2018.07.062_bib5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1089\/aivt.2016.0003","article-title":"Organs-on-Chips as bridges for predictive toxicology","volume":"2","author":"Hutson","year":"2016","journal-title":"Applied In Vitro Toxicology"},{"issue":"10","key":"10.1016\/j.biomaterials.2018.07.062_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139587","article-title":"muOrgano: a lego(r)-like plug & play system for modular multi-organ-chips","volume":"10","author":"Loskill","year":"2015","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.biomaterials.2018.07.062_bib7","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1002\/bit.25989","article-title":"Design and demonstration of a pumpless 14 compartment microphysiological system","volume":"113","author":"Miller","year":"2016","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.biomaterials.2018.07.062_bib8","series-title":"ICH Guidelines","author":"H.f.b.h. (ICH)","year":"2016"},{"issue":"1","key":"10.1016\/j.biomaterials.2018.07.062_bib9","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.2349\/biij.4.1.e5","article-title":"The importance of Good Clinical Practice guidelines and its role in clinical trials","volume":"4","author":"Vijayananthan","year":"2008","journal-title":"Biomed. Imaging Interv. J."},{"key":"10.1016\/j.biomaterials.2018.07.062_bib10","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00204-011-0769-z","article-title":"Screening of repeated dose toxicity data present in SCC(NF)P\/SCCS safety evaluations of cosmetic ingredients","volume":"86","author":"Vinken","year":"2012","journal-title":"Arch. Toxicol."},{"issue":"1","key":"10.1016\/j.biomaterials.2018.07.062_bib11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.taap.2015.03.008","article-title":"Structural and functional screening in human induced-pluripotent stem cell-derived cardiomyocytes accurately identifies cardiotoxicity of multiple drug types","volume":"285","author":"Doherty","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"2","key":"10.1016\/j.biomaterials.2018.07.062_bib12","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1476-5381.2012.02118.x","article-title":"The case for induced pluripotent stem cell-derived cardiomyocytes in pharmacological screening","volume":"169","author":"Khan","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"18","key":"10.1016\/j.biomaterials.2018.07.062_bib13","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1039\/c3lc50350j","article-title":"Microfluidic heart on a chip for higher throughput pharmacological studies","volume":"13","author":"Agarwal","year":"2013","journal-title":"Lab a Chip"},{"key":"10.1016\/j.biomaterials.2018.07.062_bib14","series-title":"Advances in Network Electrophysiology","first-page":"274","article-title":"Analysis of cardiac myocyte activity dynamics with micro-electrode arrays","author":"Egert U","year":"2006"},{"key":"10.1016\/j.biomaterials.2018.07.062_bib15","doi-asserted-by":"crossref","first-page":"4670","DOI":"10.1038\/srep04670","article-title":"On-chip in vitro cell-network pre-clinical cardiac toxicity using spatiotemporal human cardiomyocyte measurement on a chip","volume":"4","author":"Kaneko","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biomaterials.2018.07.062_bib16","doi-asserted-by":"crossref","first-page":"8883","DOI":"10.1038\/srep08883","article-title":"Human iPSC-based cardiac microphysiological system for drug screening applications","volume":"5","author":"Mathur","year":"2015","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.biomaterials.2018.07.062_bib17","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jelectrocard.2006.03.004","article-title":"Real-time multichannel system for beat-to-beat QT interval variability","volume":"39","author":"Starc","year":"2006","journal-title":"J. Electrocardiol."},{"issue":"1","key":"10.1016\/j.biomaterials.2018.07.062_bib18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/1087057110386218","article-title":"Microfluidic cell culture and its application in high-throughput drug screening: cardiotoxicity assay for hERG channels","volume":"16","author":"Su","year":"2011","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.biomaterials.2018.07.062_bib19","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.biomaterials.2015.04.035","article-title":"A phenotypic in vitro model for the main determinants of human whole heart function","volume":"60","author":"Stancescu","year":"2015","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.biomaterials.2018.07.062_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2133\/dmpk.DMPK-10-RV-089","article-title":"Role of biotransformation in drug-induced toxicity: influence of intra- and inter-species differences in drug metabolism","volume":"26","author":"Baillie","year":"2011","journal-title":"Drug Metabol. Pharmacokinet."},{"key":"10.1016\/j.biomaterials.2018.07.062_bib21","series-title":"P.C. Database","article-title":"Terfenadine","author":"NCBI","year":"2017"},{"issue":"7","key":"10.1016\/j.biomaterials.2018.07.062_bib22","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1038\/nprot.2007.229","article-title":"Differentiation of skeletal muscle and integration of myotubes with silicon microstructures using serum-free medium and a synthetic silane substrate","volume":"2","author":"Das","year":"2007","journal-title":"Nat. Protoc."},{"issue":"6","key":"10.1016\/j.biomaterials.2018.07.062_bib23","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s10439-012-0513-8","article-title":"Design optimization of liquid-phase flow patterns for microfabricated lung on a chip","volume":"40","author":"Long","year":"2012","journal-title":"Ann. Biomed. Eng."},{"issue":"18","key":"10.1016\/j.biomaterials.2018.07.062_bib24","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1016\/j.biomaterials.2010.12.022","article-title":"Patterned cardiomyocytes on microelectrode arrays as a functional, high information content drug screening platform","volume":"32","author":"Natarajan","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2018.07.062_bib25","doi-asserted-by":"crossref","first-page":"20030","DOI":"10.1038\/srep20030","article-title":"Multi-Organ toxicity demonstration in a functional human in vitro system composed of four organs","volume":"6","author":"Oleaga","year":"2016","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.biomaterials.2018.07.062_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011042","article-title":"Measurement of contractile stress generated by cultured rat muscle on silicon cantilevers for toxin detection and muscle performance enhancement","volume":"5","author":"Wilson","year":"2010","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.biomaterials.2018.07.062_bib27","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1200\/JCO.1992.10.6.995","article-title":"Cyclophosphamide pharmacokinetics: correlation with cardiac toxicity and tumor response","volume":"10","author":"Ayash","year":"1992","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.biomaterials.2018.07.062_bib28","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nrclinonc.2009.146","article-title":"Cyclophosphamide and cancer: golden anniversary","volume":"6","author":"Emadi","year":"2009","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.biomaterials.2018.07.062_bib29","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1182\/blood.V68.5.1114.1114","article-title":"Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor","volume":"68","author":"Goldberg","year":"1986","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.biomaterials.2018.07.062_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131394","article-title":"Mechanisms of fatal cardiotoxicity following high-dose cyclophosphamide therapy and a method for its prevention","volume":"10","author":"Nishikawa","year":"2015","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.biomaterials.2018.07.062_bib31","first-page":"1481","article-title":"Cyclophosphamide and 4-Hydroxycyclophosphamide\/aldophosphamide kinetics in patients receiving high-dose cyclophosphamide chemotherapy","volume":"2","author":"Anderson","year":"1996","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.biomaterials.2018.07.062_bib32","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/1752-1947-8-252","article-title":"Cardiotoxicity following cyclophosphamidetherapy: a case report","volume":"8","author":"Atalay","year":"2014","journal-title":"J. Med. Case Rep."},{"issue":"1","key":"10.1016\/j.biomaterials.2018.07.062_bib33","article-title":"Cyclophosphamide-induced cardiomyopathy: a case report, review, and recommendations for management","volume":"1","author":"Dhesi","year":"2013","journal-title":"J. Investig. Med. High Impact Case Rep."},{"issue":"12","key":"10.1016\/j.biomaterials.2018.07.062_bib34","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1093\/europace\/eup300","article-title":"Introducing a new entity: chemotherapy-induced arrhythmia","volume":"11","author":"Guglin","year":"2009","journal-title":"Europace"},{"issue":"3","key":"10.1016\/j.biomaterials.2018.07.062_bib35","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s10517-008-0287-z","article-title":"Ultrastructural signs of cyclophosphamide-induced damage to cardiomyocytes","volume":"146","author":"Lushnikova","year":"2008","journal-title":"Bull. Exp. Biol. Med."},{"issue":"4","key":"10.1016\/j.biomaterials.2018.07.062_bib36","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ctrv.2010.11.001","article-title":"Cardiovascular effects of systemic cancer treatment","volume":"37","author":"Senkus","year":"2011","journal-title":"Canc. Treat Rev."},{"issue":"10","key":"10.1016\/j.biomaterials.2018.07.062_bib37","first-page":"2723","article-title":"Plasma pharmacokinetics of cyclophosphamide and its cytotoxic metabolites after intravenous versus oral administration in a randomized, crossover trial","volume":"47","author":"Struck","year":"1987","journal-title":"Canc. Res."},{"issue":"2","key":"10.1016\/j.biomaterials.2018.07.062_bib38","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.taap.2015.03.029","article-title":"Glutathione S-transferase P protects against cyclophosphamide-induced cardiotoxicity in mice","volume":"285","author":"Conklin","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"5","key":"10.1016\/j.biomaterials.2018.07.062_bib39","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2165\/00126839-200708050-00004","article-title":"Some pharmacokinetic aspects of the lipophilic terfenadine and zwitterionic fexofenadine in humans","volume":"8","author":"Chen","year":"2007","journal-title":"Drugs R D"},{"issue":"1","key":"10.1016\/j.biomaterials.2018.07.062_bib40","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0022-3565(24)35285-1","article-title":"Loratadine blockade of K(+) channels in human heart: comparison with terfenadine under physiological conditions","volume":"292","author":"Crumb","year":"2000","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"12","key":"10.1016\/j.biomaterials.2018.07.062_bib41","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1001\/jama.1993.03500120070028","article-title":"Mechanism of the cardiotoxic actions of terfenadine","volume":"269","author":"Woosley","year":"1993","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.biomaterials.2018.07.062_bib42","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0026-895X(25)13362-2","article-title":"Effects of terfenadine and its metabolites on a delayed rectifier K+ channel cloned from human heart","volume":"44","author":"Rampe","year":"1993","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.biomaterials.2018.07.062_bib43","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1476-5381.1995.tb15873.x","article-title":"Mechanism of block of a human cardiac potassium channel by terfenadine racemate and enantiomers","volume":"115","author":"Yang","year":"1995","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.biomaterials.2018.07.062_bib44","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/j.1552-4604.1992.tb03835.x","article-title":"Pharmacokinetics of terfenadine in healthy elderly subjects","volume":"32","author":"Eller","year":"1992","journal-title":"J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.biomaterials.2018.07.062_bib45","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2165\/00003495-200059020-00020","article-title":"Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria","volume":"59","author":"Simpson","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.biomaterials.2018.07.062_bib46","series-title":"Stem Cell-derived Models in Toxicology, Methods in Pharmacology and Toxicology","first-page":"229","article-title":"Contractile force readout of hESC-cardiomyocytes","author":"Oleaga","year":"2017"},{"issue":"8","key":"10.1016\/j.biomaterials.2018.07.062_bib47","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1021\/cn300206k","article-title":"Two cell circuits of oriented adult hippocampal neurons on self-assembled monolayers for use in the study of neuronal communication in a defined system","volume":"4","author":"Edwards","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.biomaterials.2018.07.062_bib48","article-title":"Utilization of microscale silicon cantilevers to assess cellular contractile function in vitro","volume":"92","author":"Smith","year":"2014","journal-title":"JoVE"},{"issue":"10","key":"10.1016\/j.biomaterials.2018.07.062_bib49","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1039\/C5LC00237K","article-title":"Multi-cellular 3D human primary liver cell culture elevates metabolic activity under fluidic flow","volume":"15","author":"Esch","year":"2015","journal-title":"Lab a Chip"},{"key":"10.1016\/j.biomaterials.2018.07.062_bib50","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1039\/C6LC00461J","article-title":"Modular, pumpless body-on-a-chip platform for the co-culture of GI tract epithelium and primary liver tissue","volume":"16","author":"Esch","year":"2016","journal-title":"Lab a Chip"},{"key":"10.1016\/j.biomaterials.2018.07.062_bib51","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1039\/b917763a","article-title":"A microfludic device for a pharmacokinetic-pharmacodynamic (PK-PD) model on a chip","volume":"10","author":"Sung","year":"2010","journal-title":"Lab a Chip"},{"key":"10.1016\/j.biomaterials.2018.07.062_bib52","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/bit.26045","article-title":"Microfluidic blood-brain barrier model provides in vivo-like barrier properties for drug permeability screening","volume":"114","author":"Wang","year":"2017","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.biomaterials.2018.07.062_bib53","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1039\/C4LC00999A","article-title":"Pumpless Microfluidic platform for drug testing on human skin equivalents","volume":"15","author":"Abaci","year":"2015","journal-title":"Lab a Chip"},{"key":"10.1016\/j.biomaterials.2018.07.062_bib54","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/978-1-4939-2074-7_24","article-title":"Functionality testing of primary hepatocytes in culture by measuring urea synthesis","volume":"1250","author":"Bolleyn","year":"2015","journal-title":"Meth. Mol. Biol."},{"issue":"4","key":"10.1016\/j.biomaterials.2018.07.062_bib55","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/bja\/85.4.599","article-title":"The role of albumin in critical illness","volume":"85","author":"Nicholson","year":"2000","journal-title":"Br. J. Anaesth."},{"issue":"3","key":"10.1016\/j.biomaterials.2018.07.062_bib56","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1208\/s12248-013-9470-x","article-title":"Drug-drug interaction studies: regulatory guidance and an industry perspective","volume":"15","author":"Prueksaritanont","year":"2013","journal-title":"AAPS J"},{"key":"10.1016\/j.biomaterials.2018.07.062_bib57","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2174\/1389200043335531","article-title":"Cytochrome P450 and liver diseases","volume":"5","author":"Villeneuve","year":"2004","journal-title":"Curr. Drug Metabol."},{"issue":"1","key":"10.1016\/j.biomaterials.2018.07.062_bib58","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1021\/tx700079z","article-title":"Cytochrome p450 and chemical toxicology","volume":"21","author":"Guengerich","year":"2008","journal-title":"Chem. Res. Toxicol."},{"issue":"4","key":"10.1016\/j.biomaterials.2018.07.062_bib59","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.tips.2004.02.007","article-title":"Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future","volume":"25","author":"Ingelman-Sundberg","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.biomaterials.2018.07.062_bib60","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev.pharmtox.39.1.103","article-title":"Induction of cytochrome P4501A1","volume":"39","author":"Whitlock","year":"1999","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"7","key":"10.1016\/j.biomaterials.2018.07.062_bib61","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1124\/dmd.31.7.815","volume":"31","author":"Bjornsson","year":"2003","journal-title":"Drug Metab. Dispos."},{"issue":"7","key":"10.1016\/j.biomaterials.2018.07.062_bib62","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1124\/dmd.109.027029","article-title":"In vitro and in vivo induction of cytochrome p450: a survey of the current practices and recommendations: a pharmaceutical research and manufacturers of America perspective","volume":"37","author":"Chu","year":"2009","journal-title":"Drug Metab. Dispos."},{"issue":"4","key":"10.1016\/j.biomaterials.2018.07.062_bib63","first-page":"421","article-title":"Drug interactions due to cytochrome P450","volume":"13","author":"Ogu","year":"2000","journal-title":"Proc. (Bayl. Univ. Med. Cent.)"},{"issue":"8","key":"10.1016\/j.biomaterials.2018.07.062_bib64","doi-asserted-by":"crossref","first-page":"83108","DOI":"10.1063\/1.4817939","article-title":"Correlation of embryonic skeletal muscle myotube physical characteristics with contractile force generation on an atomic force microscope-based bio-microelectromechanical systems device","volume":"103","author":"Pirozzi","year":"2013","journal-title":"Appl. Phys. Lett."},{"issue":"8","key":"10.1016\/j.biomaterials.2018.07.062_bib65","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/bmc.3114","article-title":"Sensitive LC-MS\/MS-ESI method for simultaneous determination of montelukast and fexofenadine in human plasma: application to a bioequivalence study","volume":"28","author":"Muppavarapu","year":"2014","journal-title":"Biomed. Chromatogr."},{"issue":"12","key":"10.1016\/j.biomaterials.2018.07.062_bib66","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/0731-7085(96)01804-3","article-title":"Development and validation of an LC-MS-MS method for the determination of terfenadine in human plasma","volume":"14","author":"Xu","year":"1996","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.biomaterials.2018.07.062_bib67","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1007\/s00204-016-1689-8","article-title":"Fluid shear stress modulation of hepatocyte-like cell function","volume":"90","author":"Rashidi","year":"2016","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.biomaterials.2018.07.062_bib68","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1088\/0957-0233\/17\/12\/S08","article-title":"Evaluation of effects of shear stress on hepatocytes by a microchip-based system","volume":"17","author":"Tanaka","year":"2006","journal-title":"Meas. Sci. Technol."},{"issue":"2","key":"10.1016\/j.biomaterials.2018.07.062_bib69","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1124\/dmd.106.011569","article-title":"Evaluation of cryopreserved human hepatocytes as an alternative in vitro system to microsomes for the prediction of metabolic clearance","volume":"35","author":"Brown","year":"2007","journal-title":"Drug Metab. Dispos."},{"issue":"7","key":"10.1016\/j.biomaterials.2018.07.062_bib70","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0090-9556(25)06655-3","article-title":"In vitro metabolism of terfenadine by a purified recombinant fusion protein containing cytochrome P4503A4 and NADPH-P450 reductase. Comparison to human liver microsomes and precision-cut liver tissue slices","volume":"23","author":"Rodrigues","year":"1995","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.biomaterials.2018.07.062_bib71","first-page":"1","article-title":"Terfenadine t-butyl hydroxylation catalyzed by human and marmoset cytochrome P450 3A and 4F enzymes in livers and small intestines","author":"Uehara","year":"2017","journal-title":"Xenobiotica"},{"issue":"1","key":"10.1016\/j.biomaterials.2018.07.062_bib72","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jchromb.2004.02.008","article-title":"Monitoring of urinary acrolein concentration in patients receiving cyclophosphamide and ifosphamide","volume":"806","author":"Takamoto","year":"2004","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"2","key":"10.1016\/j.biomaterials.2018.07.062_bib73","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/bdd.2510020211","article-title":"Bioavailability of terfenadine in man","volume":"2","author":"Okerholm","year":"1981","journal-title":"Biopharm. Drug Dispos."},{"issue":"4","key":"10.1016\/j.biomaterials.2018.07.062_bib74","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0009-9236(97)90190-9","article-title":"Grapefruit juice-terfenadine single-dose interaction: magnitude, mechanism, and relevance","volume":"61","author":"Rau","year":"1997","journal-title":"Clin. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.biomaterials.2018.07.062_bib75","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0090-9556(25)06633-4","article-title":"Metabolism of terfenadine associated with CYP3A(4) activity in human hepatic microsomes","volume":"23","author":"Ling","year":"1995","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.biomaterials.2018.07.062_bib76","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4155\/fmc.12.197","article-title":"Cytochrome P450-activated prodrugs","volume":"5","author":"Ortiz de Montellano","year":"2013","journal-title":"Future Med. Chem."},{"issue":"12","key":"10.1016\/j.biomaterials.2018.07.062_bib77","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1039\/b612140c","article-title":"PDMS absorption of small molecules and consequences in microfluidic applications","volume":"6","author":"Toepke","year":"2006","journal-title":"Lab a Chip"},{"issue":"9","key":"10.1016\/j.biomaterials.2018.07.062_bib78","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1007\/s10439-012-0562-z","article-title":"Quantitative analysis of molecular absorption into PDMS microfluidic channels","volume":"40","author":"Wang","year":"2012","journal-title":"Ann. Biomed. Eng."},{"key":"10.1016\/j.biomaterials.2018.07.062_bib79","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1021\/ac300771z","article-title":"Comparison of biocompatibility and adsorption properties of different plastics for advanced microfluidic cell and tissue culture models","volume":"84","author":"van Midwoud","year":"2012","journal-title":"Anal. Chem."},{"issue":"2","key":"10.1016\/j.biomaterials.2018.07.062_bib80","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1124\/jpet.106.102616","article-title":"Hepatobiliary disposition of a drug\/metabolite pair: comprehensive pharmacokinetic modeling in sandwich-cultured rat hepatocytes","volume":"318","author":"Turncliff","year":"2006","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"1","key":"10.1016\/j.biomaterials.2018.07.062_bib81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cbi.2008.11.013","article-title":"Overview: evaluation of metabolism-based drug toxicity in drug development","volume":"179","author":"Li","year":"2009","journal-title":"Chem. Biol. Interact."},{"issue":"Suppl 1","key":"10.1016\/j.biomaterials.2018.07.062_bib82","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1186\/scrt369","article-title":"HeLiVa platform: integrated heart-liver-vascular systems for drug testing in human health and disease","volume":"4","author":"Vunjak-Novakovic","year":"2013","journal-title":"Stem Cell Res. Ther."},{"issue":"1","key":"10.1016\/j.biomaterials.2018.07.062_bib83","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.cbi.2008.09.026","article-title":"Metabolism Comparative Cytotoxicity Assay (MCCA) and Cytotoxic Metabolic Pathway Identification Assay (CMPIA) with cryopreserved human hepatocytes for the evaluation of metabolism-based cytotoxicity in vitro: proof-of-concept study with aflatoxin B1","volume":"179","author":"Li","year":"2009","journal-title":"Chem. Biol. Interact."},{"issue":"1","key":"10.1016\/j.biomaterials.2018.07.062_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cbi.2012.05.003","volume":"199","author":"Li","year":"2012","journal-title":"Chem. Biol. Interact."},{"issue":"3","key":"10.1016\/j.biomaterials.2018.07.062_bib85","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1021\/bp9901522","article-title":"Combining cell culture analogue reactor designs and PBPK models to probe mechanisms of naphthalene toxicity","volume":"16","author":"Ghanem","year":"2000","journal-title":"Biotechnol. Prog."},{"issue":"7","key":"10.1016\/j.biomaterials.2018.07.062_bib86","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1039\/c3lc41017j","article-title":"Microfabricated mammalian organ systems and their integration into models of whole animals and humans","volume":"13","author":"Sung","year":"2013","journal-title":"Lab a Chip"},{"issue":"1","key":"10.1016\/j.biomaterials.2018.07.062_bib87","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/bit.22219","article-title":"A novel system for evaluation of drug mixtures for potential efficacy in treating multidrug resistant cancers","volume":"103","author":"Tatosian","year":"2009","journal-title":"Biotechnol. Bioeng."},{"issue":"3","key":"10.1016\/j.biomaterials.2018.07.062_bib88","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2116\/analsci.28.197","article-title":"Micro total bioassay system for oral drugs: evaluation of gastrointestinal degradation, intestinal absorption, hepatic metabolism, and bioactivity","volume":"28","author":"Imura","year":"2012","journal-title":"Anal. Sci."},{"issue":"58","key":"10.1016\/j.biomaterials.2018.07.062_bib89","doi-asserted-by":"crossref","first-page":"36777","DOI":"10.1039\/C7RA07716E","article-title":"Integrated heart\/cancer on a chip to reproduce the side effects of anti-cancer drugs in vitro","volume":"7","author":"Kamei","year":"2017","journal-title":"RSC Adv."},{"key":"10.1016\/j.biomaterials.2018.07.062_bib90","series-title":"Japanese Society for Alternatives to Animal Experiments 14(6th World Congress on Alternatives & Animal Use in the Life Sciences)","first-page":"457","article-title":"Predictive in vitro cardiotoxicity and hepatotoxicity screening system using neonatal rat heart cells and rat hepatocytes","author":"Inoue T","year":"2007"},{"issue":"10","key":"10.1016\/j.biomaterials.2018.07.062_bib91","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1007\/s00204-013-1040-6","article-title":"The metabolic profile of mitoxantrone and its relation with mitoxantrone-induced cardiotoxicity","volume":"87","author":"Rossato","year":"2013","journal-title":"Arch. Toxicol."},{"issue":"4","key":"10.1016\/j.biomaterials.2018.07.062_bib92","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/emmm.201303800","article-title":"The heart-liver metabolic axis: defective communication exacerbates disease","volume":"6","author":"Baskin","year":"2014","journal-title":"EMBO Mol. Med."},{"issue":"7","key":"10.1016\/j.biomaterials.2018.07.062_bib93","first-page":"3022","article-title":"Fibronectin synthesized by a human hepatoma cell line","volume":"44","author":"Glasgow","year":"1984","journal-title":"Canc. Res."},{"issue":"1","key":"10.1016\/j.biomaterials.2018.07.062_bib94","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1586\/17474124.3.1.51","article-title":"The heart and the liver","volume":"3","author":"Moller","year":"2009","journal-title":"Expet Rev. Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.biomaterials.2018.07.062_bib95","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1161\/CIRCRESAHA.114.302533","article-title":"Myocardial extracellular matrix: an ever-changing and diverse entity","volume":"114","author":"Rienks","year":"2014","journal-title":"Circ. Res."},{"issue":"7","key":"10.1016\/j.biomaterials.2018.07.062_bib96","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/sj.bjp.0702944","article-title":"Novel cardiac protective effects of urea: from shark to rat","volume":"128","author":"Wang","year":"1999","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.biomaterials.2018.07.062_bib97","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jhep.2010.11.003","article-title":"The heart in liver transplantation","volume":"54","author":"Ripoll","year":"2011","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.biomaterials.2018.07.062_bib98","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00280-008-0842-3","article-title":"Nuclear receptor mediated induction of cytochrome P450 3A4 by anticancer drugs: a key role for the pregnane X receptor","volume":"64","author":"Harmsen","year":"2009","journal-title":"Canc. Chemother. Pharmacol."},{"issue":"5","key":"10.1016\/j.biomaterials.2018.07.062_bib99","first-page":"544","article-title":"Nonlinear pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide\/aldophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation","volume":"25","author":"Chen","year":"1997","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.biomaterials.2018.07.062_bib100","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0378-4347(99)00300-X","article-title":"Analysis of cyclophosphamide and five metabolites from human plasma using liquid chromatography-mass spectrometry and gas chromatography-nitrogen-phosphorus detection","volume":"732","author":"Kalhorn","year":"1999","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"issue":"3","key":"10.1016\/j.biomaterials.2018.07.062_bib101","first-page":"830","article-title":"Conversion of 4-hydroperoxycyclophosphamide and 4-hydroxycyclophosphamide to phosphoramide mustard and acrolein mediated by bifunctional catalysis","volume":"42","author":"Low","year":"1982","journal-title":"Canc. Res."},{"issue":"9206","key":"10.1016\/j.biomaterials.2018.07.062_bib102","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0140-6736(00)02051-1","article-title":"QT dispersion as a predictor of acute heart failure after high-dose cyclophosphamide","volume":"355","author":"Nakamae","year":"2000","journal-title":"Lancet"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961218305532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961218305532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T16:37:29Z","timestamp":1758904649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961218305532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":102,"alternative-id":["S0142961218305532"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2018.07.062","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation of the effect of hepatic metabolism on off-target cardiotoxicity in a multi-organ human-on-a-chip system","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2018.07.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}